- US-listed companies
- CERENOME, INC.
- Income statement
CERENOME, INC. (CNSY) Income statement
Market cap
$526.66M
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Revenue | 8 | 9 | 7 | 5 | 5 | 5 | 3 | 4 | - | - | - | - | - | 6 | 5 |
| Revenue growth (%) | - | - | - | - | - | - | - | ||||||||
| Cost of revenue | 4 | 4 | 3 | 3 | 3 | 3 | - | 1 | - | - | - | - | - | - | - |
| Gross profit | 4 | 5 | 4 | 2 | 2 | 2 | 0 | - | - | - | - | - | - | - | - |
| Gross margin (%) | - | - | - | - | - | - | - | - | |||||||
| Research & development | 11 | 14 | 17 | 15 | 19 | 16 | 12 | 9 | 5 | 3 | - | - | 10 | 11 | 8 |
| Operating margin (%) | - | - | - | - | - | ||||||||||
| Operating expenses | 36 | 39 | 39 | 37 | 24 | 28 | 25 | 17 | 11 | 10 | 12 | 20 | 18 | 21 | 21 |
| Operating income | -29,412,000 | -28,418,000 | -30,679,000 | -32,437,000 | -15,286,000 | -20 | -21 | -13 | -4 | -10 | -12 | -20 | -13 | -15 | -15 |
| Net income | -32,451,000 | -32,279,000 | -26,177,000 | -37,368,000 | -18,744,000 | -22 | -23 | -13 | -11 | -8 | -13 | -20 | -13 | -13 | -22 |
| Net income margin (%) | - | - | - | - | - | ||||||||||
| Earnings per share | - | - | - | - | - | - | - | - | - | - | - | -0.77 | -4.24 | -1.95 | -0.29 |
| Diluted EPS | -0.61 | - | - | - | - | - | - | - | - | - | - | -0.77 | -4.24 | -2.34 | -0.29 |
| EBITDA | |||||||||||||||
| EBITDA margin (%) | - | - | - | - | - |